脱铁酮
螯合作用
羟甲基
互变异构体
化学
质子化
体内
金属
水溶液中的金属离子
吡啶
儿茶酚
核化学
无机化学
离子
组合化学
立体化学
药物化学
有机化学
生物
生物技术
作者
Joanna Izabela Lachowicz,Valeria Marina Nurchi,Guido Crisponi,María de Guadalupe Jaraquemada-Peláez,Massimiliano Arca,Anna Pintus,Maria Amélia Santos,Catarina Quintanova,Lurdes Gano,Zbigniew Szewczuk,Maria Antonietta Zoroddu,Massimiliano Peana,Alicia Domínguez‐Martín,Duane Choquesillo‐Lazarte
出处
期刊:Dalton Transactions
[Royal Society of Chemistry]
日期:2016-04-21
卷期号:45 (15): 6517-6528
被引量:37
摘要
The synthesis of 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one (P1) is presented, together with the evaluation of its coordination ability towards Fe(3+), studied by a combination of chemical, computational, and animal approaches. The use of complementary analytical techniques has allowed us to give evidence of the tautomeric changes of P1 as a function of pH, and to determine their influence on the coordinating ability of P1 towards Fe(3+). The pFe(3+) value 22.0 of P1-iron complexes is noticeably higher than that of deferiprone (20.6), one of the three clinical chelating agents in therapeutic use for iron overload diseases. This is due on one side to the tautomeric change to the catechol form, and on the other to the lower protonation constant of the OH group. Bio-distribution studies on mice allowed us to confirm in vivo the efficacy of P1. Furthermore the coordinating ability toward Al(3+), Cu(2+) and Zn(2+) has been studied to evaluate the possible use of P1 against a second toxic metal ion (Al(3+)), and to envisage its potential influence on the homeostatic equilibria of essential metal ions. The chelating ability of P1 toward these ions, not higher than that of the corresponding deferiprone, contributes to render P1 a more selective iron chelator.
科研通智能强力驱动
Strongly Powered by AbleSci AI